Menarini Industrie Farmaceutiche Riunite | Finanzwire

Basculer en Français

10562	Companies
223495	Keywords
152500	Articles
118268	Press releases

Headlines Articles Press releases Menarini Industrie Farmaceutiche Riunite

Home
Companies
Menarini Industrie Farmaceutiche Riunite

BRIEF

published on 06/14/2026 at 13:35, 8 hours 2 minutes ago

Menarini Group Presents Promising Phase 3 SENTRY Trial Data

Selinexor Ruxolitinib Myelofibrosis Phase 3 SENTRY Trial Spleen Volume Reduction
PRESS RELEASE

published on 06/14/2026 at 13:30, 8 hours 7 minutes ago

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
Menarini Group presents data from Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at EHA 2026 Congress, showing significant spleen volume reduction and potential overall survival benefit

Menarini Group Selinexor Ruxolitinib Myelofibrosis Phase 3 SENTRY Trial
BRIEF

published on 06/04/2026 at 18:35, 10 days 3 hours ago

Fair Play Menarini Marks 30 Years with Celebrated Athletes

International Recognition Fair Play Menarini Sports Award 2026 Ceremony Italian Athletes
PRESS RELEASE

published on 06/04/2026 at 18:30, 10 days 3 hours ago

FROM DUPLANTIS TO PALTRINIERI, FAIR PLAY MENARINI KICKS OFF ITS 30TH EDITION
Fair Play Menarini celebrates its 30th edition with winners from various sports, promoting values of respect and integrity. Awards ceremony in Florence on July 2

Sports Awards Ceremony RESPECT Fair Play Menarini 30th Edition
BRIEF

published on 05/28/2026 at 18:55, 17 days 2 hours ago

Menarini Group Unveils ELEVATE Study Data at ASCO Meeting

Breast Cancer Menarini Group Elacestrant Capivasertib ELEVATE Study
PRESS RELEASE

published on 05/28/2026 at 18:50, 17 days 2 hours ago

Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Menarini Group presents new data from Phase 1b/2 ELEVATE Study of Elacestrant in combination with Capivasertib for ER+, HER2- Metastatic Breast Cancer at ASCO Annual Meeting 2026

Breast Cancer Menarini Group Elacestrant Capivasertib ELEVATE Study
BRIEF

published on 05/26/2026 at 13:30, 19 days 8 hours ago

Honoring Integrity at the Fair Play Menarini International Award

Integrity Sportsmanship Courage Fair Play Youth Awards
PRESS RELEASE

published on 05/26/2026 at 13:25, 19 days 8 hours ago

FAIR PLAY MENARINI INTERNATIONAL AWARD: HONOURING THREE YOUNG CHAMPIONS OF COURAGE AND HUMANITY
Menarini Industrie Farmaceutiche Riunite honours three young athletes for their integrity and fair play at the 2026 Fair Play Menarini International Award

Integrity Fair Play Menarini International Award Fair Play Menarini Industrie Farmaceutiche Riunite Young Champions
BRIEF

published on 05/25/2026 at 12:55, 20 days 8 hours ago

Menarini Group Presents Promising Oncology Data at ASCO 2026

Hematologic Malignancies Metastatic Breast Cancer ASCO 2026 Oncology Data Targeted Therapies
PRESS RELEASE

published on 05/25/2026 at 12:50, 20 days 8 hours ago

Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
Menarini Group and Stemline Therapeutics present new oncology data at ASCO 2026 Annual Meeting, showcasing potential benefits for cancer patients

Cancer Patients Menarini Group Stemline Therapeutics ASCO 2026 Oncology Data

Accesswire

Published on 06/13/2026 at 04:50, 1 day 16 hours ago

BTU Additional Details Regarding Recent Acquisition
Published on 06/13/2026 at 02:00, 1 day 19 hours ago

Battery X Metals Appoints Automotive Industry Professional from Canadian Subsidiary of One of the World's Leading Premium Automobile Manufacturers, Headquartered in Munich, Germany, to its Advisory Board to Advance Commercialization of Its Patent-Pending
Published on 06/12/2026 at 23:15, 1 day 22 hours ago

BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/12/2026 at 22:30, 1 day 23 hours ago

Fox River Provides Reminder To Vote And Updated Dissent Rights
Published on 06/12/2026 at 15:14, 2 days 6 hours ago

Reeflex Solutions Inc. Reports Voting Results From Annual and Special Meeting of Shareholders

View all ACCESSWIRE

EQS Group

Published on 06/14/2026 at 14:50, 6 hours 47 minutes ago

Zug voters say yes to Metalli development plan
Published on 06/14/2026 at 13:30, 8 hours 7 minutes ago

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
Published on 06/14/2026 at 10:42, 10 hours 54 minutes ago

LightOn Demonstrates the Flexibility of Its OCR Model by Adapting It to Arabic Through Targeted Training.
Published on 06/13/2026 at 08:18, 1 day 13 hours ago

EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands AI substrate capacity in Kulim and increases outlook for 2026/27
Published on 06/13/2026 at 01:05, 1 day 20 hours ago

OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe

Les Echos

Published on 06/12/2026 at 18:31, 2 days 3 hours ago

Share retention commitments (Dutreil agreement)
Published on 06/12/2026 at 10:34, 2 days 11 hours ago

CHANGE IN THE SHARE CAPITAL
Published on 06/12/2026 at 09:00, 2 days 12 hours ago

Pricing of Green Senior Secured Notes due 2031 by Neoen FINCO PLC
Published on 06/11/2026 at 20:30, 3 days 1 hour ago

Mersen joins the SBF 120 index
Published on 06/11/2026 at 17:45, 3 days 3 hours ago

BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026

View all LES ECHOS COMFI WIRE